These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7096608

  • 21. Relationship of desipramine plasma levels to therapeutic response: a critical reappraisal of the data.
    Friedel RO.
    J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):46-9. PubMed ID: 6384208
    [Abstract] [Full Text] [Related]

  • 22. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL, Schatzberg AF, Rosenbaum A, Contreras SA, Samson JA, Dessain E, Sayler M.
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prediction of steady-state plasma levels of amitriptyline and nortriptyline from a single dose 24 hr. level in depressed patients.
    Brunswick DJ, Amsterdam J, Schless A, Rothbart M, Sandler K, Mendels J.
    J Clin Psychiatry; 1980 Oct; 41(10):337-40. PubMed ID: 7430077
    [Abstract] [Full Text] [Related]

  • 26. Characteristics of desipramine-refractory depression.
    Nelson JC, Mazure CM, Jatlow PI.
    J Clin Psychiatry; 1994 Jan; 55(1):12-9. PubMed ID: 8294386
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. ECG effects of comparable plasma concentrations of desipramine and amitriptyline.
    Veith RC, Bloom V, Bielski R, Friedel RO.
    J Clin Psychopharmacol; 1982 Dec; 2(6):394-8. PubMed ID: 7174862
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients.
    McAleer SD, Foondun AS, Feely M, Chrystyn H.
    Chirality; 1997 Dec; 9(1):13-6. PubMed ID: 9094197
    [Abstract] [Full Text] [Related]

  • 33. The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
    Cooke RG, Warsh JJ, Stancer HC, Reed KL, Persad E.
    Clin Pharmacol Ther; 1984 Sep; 36(3):343-9. PubMed ID: 6467794
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Nonlinear desipramine kinetics: prevalence and importance.
    Nelson JC, Jatlow PI.
    Clin Pharmacol Ther; 1987 Jun; 41(6):666-70. PubMed ID: 3581650
    [Abstract] [Full Text] [Related]

  • 36. Serum imipramine concentrations lower than plasma values.
    Hullett FJ, Levy AB, Tachiki KH.
    J Clin Psychiatry; 1984 Dec; 45(12):516-8. PubMed ID: 6501238
    [Abstract] [Full Text] [Related]

  • 37. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 38. Single-dose kinetics predict steady-state concentrations on imipramine and desipramine.
    Potter WZ, Zavadil AP, Kopin IJ, Goodwin FK.
    Arch Gen Psychiatry; 1980 Mar; 37(3):314-20. PubMed ID: 7362419
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.